Table 1.

Clinical data of all subjects.

	AITD	GD	HT	Control
N	889	592	297	770
Gender	—	—	—	—
Male	220 (24.75%)	179 (30.24%)	41 (13.80%)	266 (34.55%)
Female	669 (75.25%)	413 (69.76%)	256 (86.20%)	504 (65.45%)
Age (mean ± s.d.)	36.29 ± 14.31	36.95 ± 14.70	34.96 ± 13.42	39.04 ± 8.79
Family history	—	—	—	—
(+)	181 (20.36%)	120 (20.27%)	61 (20.54%)	—
(-)	708 (79.64%)	472 (79.73%)	236 (79.46%)
Ophthalmopathy
(+)	111 (12.49%)	106 (17.91%)	5 (1.68%)	—
(-)	778 (87.51%)	486 (82.09%)	292 (98.32%)	—
Onset of age				—
≤18 years	122 (13.72%)	83 (14.02%)	39 (13.13%)	—
≥19 years	767 (86.28%)	509 (85.98%)	258 (86.87%)	—

AITD, autoimmune thyroid disease; GD, Graves' disease; HT, Hashimoto's thyroiditis.